Slide 1: Managing Director Report 6 Months to 31 Jan 2019
For personal use only Managing Director Report 6 Months to 31 Jan 2019 20 March 2019
Slide 2: Vision and Mission Statement
For personal use only Vision and Mission Statement Vision: To optimise the health and development of adults, infants and children. Mission: To deliver science based bioactives which provide health benefits to adults, infants and children. 1
Slide 3: Half Year Performance Highlights
Half Year Performance Highlights For personal use only Net Profit $4.5m up Interim fully franked 40% on half year 2018 dividend 0.625c declared Operating Revenue Inventory managed at $34.3m up 10.4% $24.8m represents on half year 2018 investment in raw materials Operating expenses of Bal
Slide 4: Half Year 2019 Results
For personal use only Half Year 2019 Results AUD million 31 Jan 2019 31 Jan 2018 • 10% half year on half year revenue growth Revenue $34.3 $31.0 • Asia, EU & US sales growth NPBT $6.2 $4.4 Tax ($1.7) ($1.2) • Overhead costs managed NPAT $4.5 $3.2 • NPAT result $4.5m (PCP $3.2m) EPS 2.71 cps 1.93 cps
Slide 5: Balance Sheet January 2019
Balance Sheet 31 January 2019 For personal use only AUD million Reported Reported Movement 31 Jan 2019 31 Jul 2018 Cash $6.2 $7.9 -$1.7 Trade $13.9 $15.3 -$1.4 Receivables •Cash balance strong $6.2m Inventories $24.8 $19.8 +$5.0 Total Current $45.2 $43.6 +$2.6 • Inventories Assets managed to meet PP
Slide 6: An Update on Growth Platforms
For personal use only An Update on Growth Platforms Focus on Infant Formula New New Product Market Development Development 5
Slide 7: Growth Platform: Focus on the infant formula market
Focus on Infant Formula For personal use only Growth Platform Focus on the infant formula market Infant formula continues to deliver growth Additional customers are trialling product with a view to adding DHA by 2020 China has extended the cross border trade and added 22 warehouses to facilita
Slide 8: Growth Platform: Creating new opportunities
For personal use only Growth Platform Creating new opportunities New products delivering alternative applications in the USA include milk, health bars and sports nutrition Vegan encapsulated product opens new opportunities in a growing segment NASSA accredited “organic input” status has result
Slide 9: Growth Platform: Expanding our market reach
For personal use only Growth Platform Expanding our market reach Business development is paying off, with growth in Asia, USA and Europe A warehouse has been established in The Netherlands along with a full time sales employee Distributors appointed over the past few years are winning contract
Slide 10: 2HFY2019 Outlook & Priorities
For personal use only 2HFY2019 Outlook & Priorities • Develop opportunities in the EU where infant formula companies must meet the new 20mg/100kcal DHA legislated requirements in 2020 • Establish additional raw material sources • Develop Chinese infant formula relationships to prepare for the propos
Slide 11: Disclaimer
For personal use only Disclaimer The release, publication or distribution of this presentation in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this presentation is released, published or distributed should inform themselves about and observe s